•
Sep 30, 2023

Mineralys Therapeutics Q3 2023 Earnings Report

EPS
-$0.57
Previous year: -$13.9
-95.9%
Gross Profit
$0
Cash and Equivalents
$254M
Previous year: $49M
+418.4%
Free Cash Flow
-$19M
Total Assets
$278M

Mineralys Therapeutics

Mineralys Therapeutics